Interobserver variability in organ at risk delineation in head and neck cancer.

Journal: Radiation oncology (London, England)
Published Date:

Abstract

BACKGROUND: In radiotherapy inaccuracy in organ at risk (OAR) delineation can impact treatment plan optimisation and treatment plan evaluation. Brouwer et al. showed significant interobserver variability (IOV) in OAR delineation in head and neck cancer (HNC) and published international consensus guidelines (ICG) for OAR delineation in 2015. The aim of our study was to evaluate IOV in the presence of these guidelines.

Authors

  • J van der Veen
    KU Leuven, Dept. Oncology, Laboratory of Experimental Radiotherapy, & UZ Leuven, Radiation Oncology, Belgium.
  • A Gulyban
    Liege University Hospital, Liège, Belgium.
  • S Willems
    KU Leuven, Dept. ESAT, Processing Speech and Images (PSI), & UZ Leuven, Medical Imaging Research Center, Belgium.
  • F Maes
    KU Leuven, Dept. ESAT, Processing Speech and Images (PSI), & UZ Leuven, Medical Imaging Research Center, Belgium.
  • S Nuyts
    KU Leuven, Dept. Oncology, Laboratory of Experimental Radiotherapy, & UZ Leuven, Radiation Oncology, Belgium. Electronic address: sandra.nuyts@uzleuven.be.